Biopsy results of the breast lesion revealed grade II invasive ductal carcinoma (IDC), which was positive for estrogen receptor (ER, 90%) and Ki-67 (30%), and negative for progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). Here, ERBB2 is linked to invasive ductal breast carcinoma.